amino acids; dextrose - Profile

What are the generic drug sources for amino acids; dextrose and what is the scope of freedom to operate?

Amino acids; dextrose is the generic ingredient in forty-seven branded drugs marketed by Abbott, Hospira, Baxter Hlthcare, and Hospira Inc, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

Summary for amino acids; dextrose

US Patents:	0
Tradenames:	47
Applicants:	4
NDAs:	15

US Patents and Regulatory Information for amino acids; dextrose

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbott	AMINOSYN 3.5% W/ DEXTROSE 25% IN PLASTIC CONTAINER	amino acids; dextrose	INJECTABLE;INJECTION	019118-001	Oct 11, 1984		DISCN	No	No
Abbott	AMINOSYN 3.5% W/ DEXTROSE 5% IN PLASTIC CONTAINER	amino acids; dextrose	INJECTABLE;INJECTION	019120-001	Oct 11, 1984		DISCN	No	No
Abbott	AMINOSYN 4.25% W/ DEXTROSE 25% IN PLASTIC CONTAINER	amino acids; dextrose	INJECTABLE;INJECTION	019119-001	Oct 11, 1984		DISCN	No	No
Abbott	AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER	amino acids; dextrose	INJECTABLE;INJECTION	019505-002	Nov 7, 1986		DISCN	No	No
Abbott	AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER	amino acids; dextrose	INJECTABLE;INJECTION	019713-006	Sep 9, 1988		DISCN	No	No
Hospira	AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER	amino acids; dextrose	INJECTABLE;INJECTION	019681-001	Nov 1, 1988		DISCN	No	No
Abbott	AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER	amino acids; dextrose	INJECTABLE;INJECTION	019506-001	Nov 7, 1986		DISCN	No	No

Amino acids; dextrose Market Analysis and Financial Projection

Last updated: February 3, 2026

What is the Market and Investment Landscape for Amino Acids and Dextrose?

The global pharmaceuticals market for amino acids and dextrose is driven by increasing demand in nutritional, medical, and biotechnological applications. The amino acids segment is valued at over $3 billion as of 2022, with a compound annual growth rate (CAGR) of approximately 7%. Dextrose, part of the glucose derivatives market, exceeds $2.5 billion with an estimated CAGR of 5.5% between 2022 and 2027 (Source: MarketsandMarkets).

Investment in these compounds primarily targets their use as excipients, nutritional supplements, and active pharmaceutical ingredients (APIs) in drug formulations. Companies with established supply chains and R&D pipelines benefit from growth in emerging markets and increased focus on personalized medicine.

How Do Market Fundamentals Drive Investment?

Supply Chain Dynamics

Amino acids are produced through fermentation or chemical synthesis. Fermentation dominates due to cost efficiency and sustainability. Major producers include Ajinomoto, CJ CheilJedang, and Evonik. Dextrose manufacturing centers are concentrated in the US, China, and Europe, with a shift towards sustainable sourcing.

Regulatory Environment

Regulatory standards for amino acids and dextrose as pharmaceutical excipients are governed by the FDA (US), EMA (Europe), and other regional authorities. Compliance with Good Manufacturing Practices (GMP) and approval processes for new formulations drive R&D investment.

Technological Innovation

Advances in fermentation technology and synthetic biology increase yield and reduce costs. The development of specialty amino acids with specific functional properties opens niche markets, attracting venture capital and corporate R&D spending.

Market Drivers

• Increasing health consciousness fuels demand for nutritional supplements.
• Rise in chronic diseases and aging populations increase need for medical nutrition.
• Growth in biologics and personalized medicine enhances demand for amino acids like L-arginine, L-lysine.
• Surge in clean-label and plant-based ingredients influences dextrose sourcing and labeling.

Competitive Landscape

Large-scale producers dominate, but innovation and vertical integration create differentiation. Companies investing in sustainable sourcing (e.g., bio-based glucose) and proprietary strains see higher margins.

What Are The Key Investment Considerations?

Factor	Impact	Details
Market Growth	Positive	CAGR of 5.5% to 7% indicates steady expansion.
Margins	Moderate	Amino acids and dextrose have moderate profit margins, driven by scale and innovation.
Regulatory Risks	Moderate	Delays or rejections by authorities can impact timelines and cost.
Raw Material Costs	Volatile	Fluctuations in natural gas, sugar prices affect production costs.
Technological Innovation	High	Breakthroughs can lead to cost advantages and new market segments.

How Do Investment Patterns Differ?

• Companies with integrated production and R&D pipelines outperform in volatile markets.
• Strategic partnerships with biotech firms amplify innovation potential.
• Geographical diversification mitigates risks associated with regional regulatory changes.

What Are the Risks and Opportunities?

Risks

• Raw material price volatility impacts margins.
• Stringent regulatory approval processes can delay commercialization.
• Competition from synthetic and plant-based alternatives intensifies.

Opportunities

• Growing demand for personalized nutrition and medical formulations.
• Expansion into emerging markets with limited current supply.
• Development of specialty amino acids for targeted therapies.

Key Takeaways

• The amino acids and dextrose markets display stable growth driven by healthcare and biotech applications.
• Investment prospects depend on technological innovations and supply chain efficiencies.
• Strategic alignment with regulatory standards and sustainability trends is crucial.
• Market penetration in emerging economies presents significant upside.
• R&D focus on specialty compounds enhances competitive advantage.

FAQs

1. What are the primary applications of amino acids in pharmaceuticals?
   They serve as building blocks in peptide drugs, active ingredients in medical nutrition, and excipients to improve drug stability and bioavailability.

2. How does the regulatory environment affect investment?
   Stringent GMP and safety standards can extend time-to-market but safeguard EMA/FDA-approved products, influencing R&D expenditure and market entry strategies.

3. What factors influence the pricing of dextrose?
   Raw material costs, primarily glucose derived from corn or sugarcane, and energy prices significantly affect pricing dynamics.

4. Are sustainable sourcing practices impacting market fundamentals?
   Yes. Bio-based glucose and fermentation-based amino acids align with global sustainability efforts, influencing product differentiation and investor interest.

5. What technological breakthroughs could reshape the market?
   Advances in synthetic biology, such as engineered microbial strains for higher yield, and process automation could lower production costs and enable new product development.

---

Sources:

[1] MarketsandMarkets. "Amino Acids Market by Type, Application, Region - Global Forecast to 2027."

[2] Fortune Business Insights. "Dextrose Market Size, Share & Industry Analysis."